IRB-Approved Treatment Protocol

Our IRB-approved protocol consists of a two-day period including the IV transplant of 300 million cord tissue-derived Mesenchymal Stem Cells (MSCs), as well as a variety of therapies designed to aid in stem cell activation and potency.


Learn more about our protocol.


Our IRB-approved protocol consists of a two-day period including the IV transplant of 300 million umbilical cord tissue-derived Mesenchymal Stem Cells (MSCs), as well as a variety of therapies designed to aid in stem cell activation and potency (musculoskeletal rehabilitation, acupuncture, lymphatic massage).

Our protocol is minimally invasive to the patient and has very little downtime. There is typically a 1-2 hour rest and recuperation period immediately following the infusion. Patients normally experience a significant increase in energy levels the day after treatment.

Treatment goals

The therapeutic uses of stem cells as a potential therapy for a variety of diseases has been immensely explored, the number of clinical trials conducted with Mesenchymal Stem Cells has increased exponentially over the past few years.

The stated primary goal of our protocol is the marked reduction in the levels of chronic low-grade inflammation for an extended period of time.

Stem cells have a unique, intrinsic property that attracts them to inflammation in the body. Studies have shown that stem cells can regenerate damaged or diseased tissues, reduce inflammation and modulate the immune system promoting better health and quality of life.

Depending on the primary ailment or initial  condition of the patient, the effects of stem cell therapy can lead to a reduction in harmful symptoms, stabalization of condition and a significant quality of life improvement.

What our protocol includes:

mesenchymal stem cells icon

300 Million Mesenchymal Stem Cells

300 million cord tissue-derived mesenchymal (live) stem cells. Delivered systemically via intravenous injection (IV).

heart icon with plus

IV Vitamin Therapy

To ensure the body is hydrated and fully prepared for treatment.

Detox icon

Detox Regime

We will guide you through the pre-treatment detox regime in order to prepare your body for optimal stem cell activation.

Medical equipment svg icon

Stem Cell Activation Therapies

A musculoskeletal assessment, followed by acupuncture & physiotherapy. Lymphatic drainage massage is also utilized.

icon of human with brain

Cell Activation Supplements

A 2 month supply of Stemulife™ supplements. An all natural supplement aimed at increasing stem cell effectiveness.

Man celebrating

Minimally Invasive Treatment

Natural healing picture

Improve Bodies Natural Healing Ability

Patient satisfaction

Patients Report Significant Improvement

Safe protocol

Timely, Safe, Regulated Protocol


Learn more about our stem cells.

Type of stem cells administered

Our protocol involves the systemic administration of 300 million Mesenchymal Stem Cells derived from American Association of Tissue Bank (AATB) certified suppliers of full term (>36 weeks), donated human umbilical cords.

Our partner lab

DVC Stem is partnered with an award-winning medical laboratory located in the United States, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified. All of our cells are expanded using safe and standard protocols and are then flown overnight in sub-zero CryoPort™ containers directly to our clinic for treatment. To ensure maximum treatment effectiveness, all of our cells are ISCT tested for viability prior to use.

Regulation & donor screening

Our partner lab only uses American Association of Tissue Bank (AATB) certified suppliers of full-term (>36 weeks), donated human umbilical cords. The selection of these donated tissues is extremely regulated and strict. The cords are tested for STDs, Hep A/B/C/D, TB, Zika virus, no history of cancer or chronic illness, no history of autoimmune diseases, no tattoos or piercings, no travel abroad with one year, no history of CJD, negative for HIV, negative for HTLV 1 AND 2, and no history of drug or alcohol abuse. After the tissue is vigorously screened and accepted, our lab uses a clinical-grade and award-winning proprietary culture medium to expand the stem cells out to roughly 300 million cells per treatment. Full international and domestic compliance & regulations are followed.

Stem Cell Icon


All of our cells are tested to International Society Cell & Gene Therapy (ISCT) standards for viability to ensure they meet minimum QA requirements multiple times before treatment. These reports can be provided to the patient for their review upon request.

Search Magnifying Glass Icon

Quality Control

Cells are rigorously tested for potency, blood-borne pathogens, contaminating agents, fungal presence, cellular ATP levels, and proper growth rates. The entire production process is completed in a certified sterile clean room, which must meet all regulations by the FDA, ISO, and CLIA.

Safety Icon


Cord-tissue derived mesenchymal stem cells do not face immune rejection within the body. These are primal, immune-privileged, undifferentiated cells. There are no blood products associated with them either, removing the need for a donor match; they are accepted universally.

Why use cord tissue derived stem cells?

Umbilical cord tissue is a natural bi-product of child birth, but also rich in mesenchymal stem cells which can be used to help heal, regenerate, and treat a variety of conditions.

Cord-tissue derived mesenchymal stem cells do not face immune rejection within the body. They are youthful, immuno-privileged, undifferentiated cells that have yet to be “claimed.” There are also no blood products associated with them, removing the need for HLA matching; cord tissue derived mesenchymal stem cells are universally accepted.

Recent studies have shown that although stem cells can be found in every living person, their numbers and potency can diminish with age. Additionally, cells sourced from the tissues of those patients with autoimmune/degenerative conditions may contain components of those disorders, detracting from the effectiveness of their use in treatments. Cord tissue derived stem cells bypass both of these issues, while remaining minimally invasive to the patient, and always available for immediate use.

FDA Registered Facility
Clinical Laboratory Improvement Amendment
ISO Certification
ISO Certification

Learn more about our partner lab Vitro Biopharma here

Our trusted partners


Learn more about our treatment.

2-day non-invasive treatment

Our treatment consists over a two-day period which includes the systemic intravenous (IV) transplant of 300 Million cord tissue-derived MSCs, as well as a variety of therapies designed to aid stem cell activation. The procedure is minimally invasive (single IV transfusion) and has very little downtime. Most patients are able to travel the day after treatment. Day one and four are included to account for travel days, the minimum amount of time spent in Grand Cayman should be no less than 5 days.


Day One

Meet the team, complete physical assessments & supporting therapies.


Day Two

Stem cell infusion & additional activation therapies.


Day Three

Follow-up physical.

The stem cell infusion

The stem cell infusion will include the intravenous (IV) transplant of 300 million cord tissue-derived mesenchymal stem cells (MSCs). These cells are only administered by our Medical Director, over the course of a few hours to ensure proper circulation and maximum control over the procedure. The infusion occurs at our facility in our VIP treatment room, with a private adjacent space for resting and recuperation post-treatment.

Additional stem cell activation therapies

Our protocol utlizes additional therapies prior to and post-treatment to help activate natural stem cell production within the body. We aim to position the patient into an optimal state to receive the influx of new stem cells.

The supporting therapies that are included in our protocol are:

• Musculoskeletal Assessment
• Immune Balancing Acupuncture
• Lymphatic Drainage Massage
• IV Vitamin Therapy

Patient Image
Da Vinci Centre, Cayman
Patient Image


Meet our Medical Director.

Treatment performing physician

Our Medical Director, Dr. Cona is the treatment performing physician here at DVC Stem. We make sure to schedule no more that 2 patients per day so every patient has our full undivided attention during the treatment process.

Medical accreditation

Dr. Cona has been a pioneer in regenerative cell therapy, providing the first stem cell treatments in the Cayman Islands over a decade ago.

He continues to research alternative therapies for various medical conditions, and with IRB certified clinical trials, he has treated local and international patients successfully for Multiple Sclerosis (MS), Chronic Low-Grade Inflammation which is part of the overall Aging Process, as well as many other degenerative conditions.​

Dr. Cona is certified by the American Academy of Aesthetic Practitioners and is also a member of the World Academy of Anti-Aging Medicine (WAAAM). He is also a recognized member of the British Medical Association, the General Medical Council (UK), the Caribbean College of Family Physicians, and the American Academy of Family Physicians.

Dr. Louis A. Cona

Louis A. Cona, MD


IRB Approved Protocol


Day Treatment


Million MSCs


Years of Stem Cell Experience


Learn more about our clinic.


DVC Stem is located in Grand Cayman, a small island paradise in the Caribbean. As a British Overseas Territory, healthcare regulations are extremely strict, on par with the US, UK, and EU. Additionally, our entire medical staff is fully registered and licensed, and our stem cell protocols are IRB reviewed and approved by a board in the United States. The Cayman Islands is a safe, English-speaking British Overseas Territory and hosts over 2 million tourists a year.

There are many direct flights to Grand Cayman from major cities in the United States, Canada and Europe. DVC Stem is located within the Da Vinci Centre a large modern medical facility directly on Seven Mile Beach.

Seven Mile Beach Aerial Photograph
DVC Stem Logo

Clinic Highlights

mesenchymal stem cells icon

Highly Regulated

As a British Overseas Territory, healthcare regulations are extremely strict, on par with the US, UK, and EU.

heart icon with plus

US Sourced Stem Cells

DVC Stem is partnered with an award-winning medical laboratory located in the United States, which is fully FDA registered, cGMP compliant, ISO 9001, and ISO 13485 certified.

Detox icon

Experienced Medical Staff

Every patient is under constant supervision by our Medical Director and two registered nurses.

Medical equipment svg icon

Dedicated Patient Success Team

Our patient management team will happily guide you through the onboarding process.

icon of human with brain

Beautiful Location

Our clinic is located directly on the world famous Seven Mile Beach, one block away from the Ritz Carlton Resort.


Measuring treatment results.

"We measure inflammation markers and telomere length both pre and post treatment. We also follow up with patients at 3, 6, 9 and 12 month mark intervals with vitality questionnaires. These are extremely important because they enable us to measure patient satisfaction in relation to treatment efficacy."

- Louis A. Cona, MD

Treatment results

We only offer treatments for conditions that have medical research backing positive results and no harmful side effects. Dozens of studies have shown the efficacy of stem cell therapies for various degenerative diseases, and we have had great success from our past patients. Patients normally experience an increase in mobility, sensation, balance, strength, & energy along with a reduction in stress and pain levels.

However, it is impossible to guarantee any specific result for an individual, as every person’s body is unique and will respond in different ways.

Our re-treatment protocol

Our official treatment protocol does not require that patients repeat treatment. Our goal is to help manage symptoms and slow progression, so that our patients won't have to return.

Approximately 85% of first-time patients report a significant improvement in their condition within the first 3 months following their treatment date.